1.27
1.27 (-1.15%)
As of Jun 14, 2022
Transcode Therapeutics, Inc. [RNAZ]
Source:
Company Overview
TransCode is an RNA oncology company created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. Our lead therapeutic candidate, TTX-MC138, targets microRNA-10b, or miRNA-10b, a master regulator of metastatic cell viability in a range of cancers, including breast, pancreatic, ovarian, colon cancer, glioblastomas, and several others.
| Country | United States |
| Headquarters | boston, massachusetts |
| Phone Number | 857-301-6857 |
| Industry | |
| CEO | R. Michael Dudley |
| Website | www.clinicaltrials.gov |